TNF and tuberculosis: Immunosuppressive therapies frequently used in the treatment of RA (especially TNF-α inhibitors) have been known to induce reactivation of latent T. gondii infection in arthritis patients, and may increase their propensity to acquire new opportunistic infections such as T. gondii or tuberculosis [28].